These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 9326613

  • 1. A transformation-associated complex involving tyrosine kinase signal adapter proteins and caldesmon links v-erbB signaling to actin stress fiber disassembly.
    McManus MJ, Lingle WL, Salisbury JL, Maihle NJ.
    Proc Natl Acad Sci U S A; 1997 Oct 14; 94(21):11351-6. PubMed ID: 9326613
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Tyrosine phosphorylation of caldesmon is required for binding to the Shc.Grb2 complex.
    Wang Z, Danielsen AJ, Maihle NJ, McManus MJ.
    J Biol Chem; 1999 Nov 19; 274(47):33807-13. PubMed ID: 10559276
    [Abstract] [Full Text] [Related]

  • 4. Grb2 regulation of the actin-based cytoskeleton is required for ligand-independent EGF receptor-mediated oncogenesis.
    Boerner JL, Danielsen AJ, Lovejoy CA, Wang Z, Juneja SC, Faupel-Badger JM, Darce JR, Maihle NJ.
    Oncogene; 2003 Oct 02; 22(43):6679-89. PubMed ID: 14555981
    [Abstract] [Full Text] [Related]

  • 5. Analysis of the role of the Shc and Grb2 proteins in signal transduction by the v-ErbB protein.
    Meyer S, LaBudda K, McGlade J, Hayman MJ.
    Mol Cell Biol; 1994 May 02; 14(5):3253-62. PubMed ID: 7909355
    [Abstract] [Full Text] [Related]

  • 6. Identification of the binding site for the Shc protein to the avian erythroblastosis virus (AEV-H) v-erbB protein.
    Labudda K, Meyer S, Hayman MJ.
    Virology; 1995 Jan 10; 206(1):269-75. PubMed ID: 7831781
    [Abstract] [Full Text] [Related]

  • 7. High affinity IgG receptor activation of Src family kinases is required for modulation of the Shc-Grb2-Sos complex and the downstream activation of the nicotinamide adenine dinucleotide phosphate (reduced) oxidase.
    Park RK, Erdreich-Epstein A, Liu M, Izadi KD, Durden DL.
    J Immunol; 1999 Dec 01; 163(11):6023-34. PubMed ID: 10570290
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Novel recruitment of Shc, Grb2, and Sos by fibroblast growth factor receptor-1 in v-Src-transformed cells.
    Curto M, Frankel P, Carrero A, Foster DA.
    Biochem Biophys Res Commun; 1998 Feb 13; 243(2):555-60. PubMed ID: 9480847
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling.
    Li S, Couvillon AD, Brasher BB, Van Etten RA.
    EMBO J; 2001 Dec 03; 20(23):6793-804. PubMed ID: 11726515
    [Abstract] [Full Text] [Related]

  • 12. Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer.
    Dankort D, Maslikowski B, Warner N, Kanno N, Kim H, Wang Z, Moran MF, Oshima RG, Cardiff RD, Muller WJ.
    Mol Cell Biol; 2001 Mar 03; 21(5):1540-51. PubMed ID: 11238891
    [Abstract] [Full Text] [Related]

  • 13. Ligand-independent oncogenic transformation by the EGF receptor requires kinase domain catalytic activity.
    Danielsen AJ, Maihle NJ.
    Exp Cell Res; 2002 Apr 15; 275(1):9-16. PubMed ID: 11925101
    [Abstract] [Full Text] [Related]

  • 14. Formation of Shc/Grb2- and Crk adaptor complexes containing tyrosine phosphorylated Cbl upon stimulation of the B-cell antigen receptor.
    Smit L, van der Horst G, Borst J.
    Oncogene; 1996 Jul 18; 13(2):381-9. PubMed ID: 8710377
    [Abstract] [Full Text] [Related]

  • 15. Mechanism of SHIP-mediated inhibition of insulin- and platelet-derived growth factor-stimulated mitogen-activated protein kinase activity in 3T3-L1 adipocytes.
    Sharma PM, Son HS, Ugi S, Ricketts W, Olefsky JM.
    Mol Endocrinol; 2005 Feb 18; 19(2):421-30. PubMed ID: 15486046
    [Abstract] [Full Text] [Related]

  • 16. Phosphorylation of the SHC proteins on tyrosine correlates with the transformation of fibroblasts and erythroblasts by the v-sea tyrosine kinase.
    Crowe AJ, McGlade J, Pawson T, Hayman MJ.
    Oncogene; 1994 Feb 18; 9(2):537-44. PubMed ID: 8290264
    [Abstract] [Full Text] [Related]

  • 17. Ras-independent oncogenic transformation by an EGF-receptor mutant.
    Boerner JL, McManus MJ, Martin GS, Maihle NJ.
    J Cell Sci; 2000 Mar 18; 113 ( Pt 6)():935-42. PubMed ID: 10683142
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Involvement of proline-rich tyrosine kinase 2 in platelet activation: tyrosine phosphorylation mostly dependent on alphaIIbbeta3 integrin and protein kinase C, translocation to the cytoskeleton and association with Shc through Grb2.
    Ohmori T, Yatomi Y, Asazuma N, Satoh K, Ozaki Y.
    Biochem J; 2000 Apr 15; 347(Pt 2):561-9. PubMed ID: 10749687
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.